An observational claims data analysis on the risk of maternal chronic kidney disease after preterm delivery and preeclampsia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 06 2021
Historique:
received: 06 02 2021
accepted: 03 06 2021
entrez: 16 6 2021
pubmed: 17 6 2021
medline: 27 10 2021
Statut: epublish

Résumé

Women with complications of pregnancy such as preeclampsia and preterm birth are at risk for adverse long-term outcomes, including an increased future risk of chronic kidney disease (CKD) and end-stage kidney disease (ESKD). This observational cohort study aimed to examine the risk of CKD after preterm delivery and preeclampsia in a large obstetric cohort in Germany, taking into account preexisting comorbidities, potential confounders, and the severity of CKD. Statutory claims data of the AOK Baden-Wuerttemberg were used to identify women with singleton live births between 2010 and 2017. Women with preexisting conditions including CKD, ESKD, and kidney replacement therapy (KRT) were excluded. Preterm delivery (< 37 gestational weeks) was the main exposure of interest; preeclampsia was investigated as secondary exposure. The main outcome was a newly recorded diagnosis of CKD in the claims database. Data were analyzed using Cox proportional hazard regression models. The time-dependent occurrence of CKD was analyzed for four strata, i.e., births with (i) neither an exposure of preterm delivery nor an exposure of preeclampsia, (ii) no exposure of preterm delivery but exposure of at least one preeclampsia, (iii) an exposure of at least one preterm delivery but no exposure of preeclampsia, or (iv) joint exposure of preterm delivery and preeclampsia. Risk stratification also included different CKD stages. Adjustments were made for confounding factors, such as maternal age, diabetes, obesity, and dyslipidemia. The cohort consisted of 193,152 women with 257,481 singleton live births. Mean observation time was 5.44 years. In total, there were 16,948 preterm deliveries (6.58%) and 14,448 births with at least one prior diagnosis of preeclampsia (5.61%). With a mean age of 30.51 years, 1,821 women developed any form of CKD. Compared to women with no risk exposure, women with a history of at least one preterm delivery (HR = 1.789) and women with a history of at least one preeclampsia (HR = 1.784) had an increased risk for any subsequent CKD. The highest risk for CKD was found for women with a joint exposure of preterm delivery and preeclampsia (HR = 5.227). These effects were the same in magnitude only for the outcome of mild to moderate CKD, but strongly increased for the outcome of severe CKD (HR = 11.90). Preterm delivery and preeclampsia were identified as independent risk factors for all CKD stages. A joint exposure or preterm birth and preeclampsia was associated with an excessive maternal risk burden for CKD in the first decade after pregnancy. Since consequent follow-up policies have not been defined yet, these results will help guide long-term surveillance for early detection and prevention of kidney disease, especially for women affected by both conditions.

Identifiants

pubmed: 34131246
doi: 10.1038/s41598-021-92078-2
pii: 10.1038/s41598-021-92078-2
pmc: PMC8206322
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12596

Références

PLoS Med. 2020 Aug 14;17(8):e1003255
pubmed: 32797043
Arch Gynecol Obstet. 2021 Jan;303(1):113-119
pubmed: 32803396
Nat Rev Nephrol. 2018 Mar;14(3):203-210
pubmed: 29380816
Hypertension. 2013 Mar;61(3):641-6
pubmed: 23319540
JAMA Netw Open. 2020 Feb 5;3(2):e1920964
pubmed: 32049292
Am J Epidemiol. 2009 Jul 15;170(2):148-58
pubmed: 19509320
Am J Obstet Gynecol. 2014 Feb;210(2):147.e1-8
pubmed: 24060448
Acta Obstet Gynecol Scand. 2020 Sep;99(9):1107-1109
pubmed: 32609893
Clin Perinatol. 2008 Mar;35(1):53-67, viii
pubmed: 18280875
Arch Gynecol Obstet. 2005 Apr;271(4):338-42
pubmed: 15083307
JAMA. 2013 Jun 12;309(22):2362-70
pubmed: 23757084
Biochem Pharmacol. 2015 Jun 15;95(4):211-26
pubmed: 25916268
Paediatr Perinat Epidemiol. 2008 Mar;22(2):162-71
pubmed: 18298691
Microcirculation. 2002 Jul;9(3):147-60
pubmed: 12080413
J Obstet Gynaecol Can. 2018 Sep;40(9):1129-1138
pubmed: 29934233
BMJ. 2017 Jul 12;358:j3078
pubmed: 28701333
Nephrol Dial Transplant. 2010 Oct;25(10):3289-96
pubmed: 20348149
Am J Physiol Regul Integr Comp Physiol. 2018 Sep 1;315(3):R521-R528
pubmed: 29897824
BJOG. 2018 Jul;125(8):1009-1017
pubmed: 29193660
Semin Fetal Neonatal Med. 2016 Apr;21(2):74-9
pubmed: 26740166
Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):
pubmed: 28228456
BMJ. 2007 Nov 10;335(7627):978
pubmed: 17975256
Atherosclerosis. 2004 Aug;175(2):189-202
pubmed: 15262174
Am J Obstet Gynecol. 2012 Feb;206(2):143.e1-8
pubmed: 22036665
Paediatr Perinat Epidemiol. 2010 Jul 1;24(4):323-30
pubmed: 20618721
Circulation. 2012 Mar 20;125(11):1367-80
pubmed: 22344039
CMAJ. 2013 Feb 19;185(3):207-13
pubmed: 23339156
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
Kidney Int. 2019 Sep;96(3):711-727
pubmed: 31352975
Nat Clin Pract Nephrol. 2007 Nov;3(11):613-22
pubmed: 17957198
Dtsch Arztebl Int. 2019 Dec 13;116(50):858-864
pubmed: 31931955
Circulation. 2011 Jun 21;123(24):2856-69
pubmed: 21690502
Diabetes Care. 2004 Dec;27(12):2824-8
pubmed: 15562192
BMC Pregnancy Childbirth. 2013 Mar 09;13:61
pubmed: 23497157
Curr Opin Obstet Gynecol. 2003 Dec;15(6):465-71
pubmed: 14624211
PLoS Med. 2019 Jul 30;16(7):e1002875
pubmed: 31361741
Cell Mol Immunol. 2014 Nov;11(6):571-81
pubmed: 24954221
Nephrol Dial Transplant. 2010 Nov;25(11):3600-7
pubmed: 20494895
J Clin Epidemiol. 2013 Mar;66(3):268-77
pubmed: 23116690
Placenta. 2009 Jul;30(7):619-24
pubmed: 19464055
Lancet. 2017 Oct 21;390(10105):1888-1917
pubmed: 28434650
BMC Med. 2020 Apr 1;18(1):66
pubmed: 32234061
Diabetologia. 2016 Dec;59(12):2518-2526
pubmed: 27646865
Front Cardiovasc Med. 2019 Nov 29;6:178
pubmed: 31850374
Int J Cardiol. 2019 May 1;282:81-87
pubmed: 30773269
J Matern Fetal Neonatal Med. 2017 May;30(9):1102-1107
pubmed: 27334094
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778
N Engl J Med. 2008 Aug 21;359(8):800-9
pubmed: 18716297
Am J Obstet Gynecol. 1999 Oct;181(4):1026-35
pubmed: 10521771
BMJ. 2019 Apr 29;365:l1516
pubmed: 31036557
J Leukoc Biol. 2016 Jan;99(1):67-78
pubmed: 26538528

Auteurs

Maren Goetz (M)

Department of General Pediatrics, University Children's Hospital, Heidelberg, Germany.

Mitho Müller (M)

Department of Psychology, Ludwig Maximilian University, Munich, Germany.

Raphael Gutsfeld (R)

Department of Psychology, Ludwig Maximilian University, Munich, Germany.

Tjeerd Dijkstra (T)

Department of Women's Health, University Hospital Tuebingen, Tuebingen, Germany.

Kathrin Hassdenteufel (K)

Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.

Sara Yvonne Brucker (SY)

Department of Women's Health, University Hospital Tuebingen, Tuebingen, Germany.

Armin Bauer (A)

Department of Women's Health, University Hospital Tuebingen, Tuebingen, Germany.

Stefanie Joos (S)

Institute for General Practice and Interprofessional Care, University Hospital Tuebingen, Tuebingen, Germany.

Miriam Giovanna Colombo (MG)

Institute for General Practice and Interprofessional Care, University Hospital Tuebingen, Tuebingen, Germany.

Sabine Hawighorst-Knapstein (S)

Department of Health Promotion, AOK Baden-Wuerttemberg, Stuttgart, Germany.

Ariane Chaudhuri (A)

Department of Health Promotion, AOK Baden-Wuerttemberg, Stuttgart, Germany.

Gudula Kirtschig (G)

Department of Health Promotion, AOK Baden-Wuerttemberg, Stuttgart, Germany.

Frauke Saalmann (F)

Department of Health Promotion, AOK Baden-Wuerttemberg, Stuttgart, Germany.

Stephanie Wallwiener (S)

Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. stephanie.wallwiener@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH